About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 7777 record(s)
Req # A-2024-000007
Adverse Drug Reactions (ADRs) for Heparin. Report numbers: 001072985.Organization: Health Canada
April 2024
Req # A-2024-000012
Adverse Drug Reactions (ADRs). Report numbers: 001067949, 001069982.Organization: Health Canada
April 2024
Req # A-2024-000017
Adverse Drug Reaction (ADR) for ACITRETIN. Report number: 1071472. ADRs for ANASTROZOLE. Report numbers: 983160, 990116. ADR for CIPROFLOX. Report number: 1032025. ADR for Clonidine. Report number: 981372. ADRs for EPLERENONE. Reports number: 1026516, 1043922. ADRs for HYDROXYCHLOROQUINE. Report numbers: 1024918, 1026702, 1037377.Organization: Health Canada
April 2024
Req # A-2024-000028
Adverse Drug Reactions (ADRs) for Rosuvastatin-40. Report numbers: 000657015, 000702528. ADRs for Rosuvastatin-10. Report numbers: 000675846, 000928844. ADRs for Rosuvastatin-5. Report numbers: 000698101, 000705573. ADRs for Rosuvastatin-20. Report numbers: 000709470, 000720165.Organization: Health Canada
April 2024
Req # A-2024-000032
Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001049833, 001051635, 001052031, 001052040, 001052619, 001050859, 001053224, 001055320, 001065019, 001065607.Organization: Health Canada
April 2024
Req # A-2024-000068
Adverse Drug Reaction (ADR) for YESCARTA. Report number: 001076510.Organization: Health Canada
April 2024
Req # A-2023-00418
Provide all reocrds of discussions between employees of PCO and Paul Kershaw (or any other representatives of Generation Squeeze). Time frame: March 1, 2023 to August 28, 2023.Organization: Privy Council Office
April 2024
Req # A-2021-00258
Copy of all documents from the meeting of Cabinet or Cabinet Committees between September 11, 2001 and October 11, 2001 regarding or related to the terrorist attacks of September 11.Organization: Privy Council Office
April 2024
Req # A-2021-00266
Provide all documents, memoranda, e-mails, correspondence, briefing notes, and any other records, including drafts, from March 3, 2021, to the present (October 25, 2021), respecting (1) the conduct of a general election or by-elections during the COVID-19 pandemic; (2) the study by the Standing Committee on Procedure and House Affairs on the conduct of an election during a pandemic, including the Committee's interim and final reports, tabled on December 11, 2020, and February 26, 2021, respectively; and (3) Bill C-19, An Act to amend the Canada Elections Act (COVID-19 response), including its parliamentary debate and consideration by the Standing Committee on Procedure and House Affairs.Organization: Privy Council Office
April 2024
Req # A-2024-00490
Provide all transition and other briefing materials from August 1 to December 31, 2021, prepared for (1) the Leader of the Government in the House of Commons, and (2) the Minister of Intergovernmental Affairs, Infrastructure and Communities with respect to his responsibilites for "democratic institutions" files.Organization: Privy Council Office
April 2024